$LMED

LataMed AI Corp. (OTC: LMED) announced its mobile healthcare app is in final testing, with plans to launch on Apple App Store and Google Play in coming weeks. The app will serve as a primary access point to its digital healthcare ecosystem, offering tools for users and healthcare providers. The company believes mobile accessibility is crucial for its strategy in Latin America. LataMed AI is also developing AI-supported technologies like CardioAI, PulmoAI, and NeuroAI.

LataMed AI Corp. (OTC: LMEDD) said its previously announced 5-for-1 forward stock split became effective at the opening of trading after publication on the FINRA Daily List dated July 14, 2026. Shares began trading under temporary symbol LMEDD, expected to revert in about 20 business days, alongside a mandatory share exchange and new CUSIP 21116R404.

LataMed AI Corp. (OTC: LMED) said it has provided FINRA with requested information for its previously announced 5-for-1 forward stock split and mandatory share exchange. Management expects the corporate action could become effective within about a week, pending FINRA review. The split will use new CUSIP 21116R404, replacing the current one.